back, the patient suddenly felt dizzy and became pale and diaphoretic and her BP decreased to 62/48 mmHg. No drug had been administered through the catheter at this time. The heart rate remained at 140 -146 beats/min with sinus tachycardia. The patient was placed in the supine position and turned to her left side, and oxygen was administered via facemask. Fluids were infused rapidly, and a total of 50 mg ephedrine was administered intravenously in divided doses in 2 to 3 min. BP increased to 112/53 mmHg, but the patient continued to experience dizziness and "feeling faint." There was no evidence of motor block, and sensory level to pin prick was at the T10 dermatome. At this time, her blood sugar was 57 mg/dl. With rapid administration of 5% dextrose, blood sugar increased to 128 mg/dl, and all symptoms were alleviated. The epidural catheter was subsequently used to provide pain relief for labor for several hours, and she delivered a healthy infant with an Apgar score of 9 and 9 at 1 and 5 min.
Rapid onset of intense analgesia after CSE can decrease the BP to levels before the onset of painful contractions in parturients, but it seldom causes profound hypotension as in this patient. Decreased venous return resulting from aortocaval compression and sympathectomy can also cause hypotension. In our patient, aortocaval compression was unlikely because the procedure was performed with the patient in the sitting position. With a sensory level of T10, the sympathetic block can extend a few segments higher, causing a decrease in the BP. However, even after the restoration of BP with fluids and ephedrine, the patient remained dizzy and diaphoretic. The symptoms disappeared with the rapid administration of intravenous dextrose. In this patient, blood sugar levels had been stable before CSE placement, necessitating no insulin therapy. The cause of acute hypoglycemia and its relation, if any, to profound hypotension after CSE is unclear. We speculate that the abrupt decrease in the levels of catecholamines and cortisol associated with the rapid onset of analgesia from intrathecal opioids may have triggered these rare events in this patient.
Positive Breath Alcohol Readings following "Generic" Propofol Administration
To the Editor:-In a previously described method, 1 the use of a breath alcohol analyzer combined with the addition of an ethanol marker to irrigation fluid allowed the detection of rapid fluid absorption during operative hysteroscopy. Our usual anesthetic technique for such procedures involves propofol induction and maintenance with periodic end-tidal breath alcohol determinations to detect the presence of ethanol from absorbed irrigation fluid. The device used to detect the ethanol marker is an Alco-Sensor III (Intoximeters, Inc., St. Louis, MO). This device analyzes discrete samples taken as needed from the patient's expired gas flow and uses fuel-cell technology together with an algorithm to provide a readout. This readout is calibrated to correspond with g/100 ml of blood ethanol and is approved by the U.S. Department of Transportation for evidentiary use. The device is not, however, specific for ethanol, and it will respond to other alcohols as well. Because the algorithm for producing the readout depends on the assumption that the alcohol measured is ethanol, it is not known how other substances relate to the device readout.
With the introduction of an alternative formulation of propofol, pharmacoeconomic considerations led to the use of the preparation manufactured by Gensia-Sicor (Irvine, CA). Shortly thereafter, it was noted that a patient undergoing hysteroscopic surgery showed positive breath alcohol levels before the start of surgery. This was initially attributed to alcohol use by the patient; however, more than 12 subsequent patients administered the Gensia-Sicor formulation were observed, and all were noted to have positive breath alcohol readings only after induction of anesthesia, but before surgery. It was also noted that discontinuing the propofol infusion and switching to sevoflurane eliminated the presence of positive readings and that the reinstitution of the infusion caused a reappearance of the positive readings. Further, positive breath alcohol readings were never present if the brand-name propofol, Diprivan (Astra-Zeneca, Wilmington, DE), was used. The readout on the device after a standard induction dose of the Gensia-Sicor propofol was from 0.010 to 0.020 gm/100 ml, a reading that, if a result of ethanol from fluid absorption, would cause discontinuation of the procedure. The response characteristics of the instrument during these circumstances are also curious. Upon taking a sample of known ethanol, the reading increases and stabilizes within a few seconds, whereas when measuring the sample of a patient administered the Gensia-Secor preparation, the reading increases over the course of as much as 1 min before stabilizing.
These findings have been discussed with the manufacturers of both the generic and the brand-name drugs, but, to date, neither has supplied an explanation. There are differences in the formulation of the two preparations, but no alcohols are added to the Gensia-Sicor formulation. Whatever the cause, further investigation of the source of the phenomenon is warranted because the use of breath alcohol sampling by fuel-cell-based instruments is unreliable in patients administered generic propofol. 
